A meta-analysis has demonstrated consistent efficacy in heart failure outcomes with SGLT2 inhibitors regardless of disease ...

There is a strong opportunity in the heart failure (HF) space for new agents that could reduce HF-associated hospitalisations ...

If approved, Novo Nordisk's Ozempic will become the first GLP-1 therapy option for patients with type 2 diabetes and chronic ...

Experts discuss the relationship between obesity and heart failure while referencing new clinical trial results.

The Post-Transplant Lymphoproliferative Disorder drugs in development market research report provides comprehensive information on the therapeutics under development for Post-Transplant ...

The Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency drugs in development market research report provides comprehensive information on the therapeutics under development for Aromatic l-Amino Acid ...

The Alpha Thalassaemia drugs in development market research report provides comprehensive information on the therapeutics under development for Alpha Thalassaemia, complete with analysis by stage of ...

The Necrotizing Enterocolitis drugs in development market research report provides comprehensive information on the therapeutics under development for Necrotizing Enterocolitis, complete with analysis ...

GlobalData tracks 13 drugs in development for Primary Sjogren's Syndrome by 12 companies/universities/institutes. The top development phase for Primary Sjogren's Syndrome is phase ii, with eight drugs ...

GlobalData tracks 11 drugs in development for Crimean-Congo Hemorrhagic Fever by eight companies/universities/institutes. The top development phase for Crimean-Congo Hemorrhagic Fever is preclinical, ...

GlobalData tracks 7 drugs in development for Cushing's Syndrome by six companies/universities/institutes. The top development phase for Cushing's Syndrome is preclinical, with two drugs in that stage.

GlobalData tracks 7 drugs in development for Corneal Ulcers by seven companies/universities/institutes. The top development phase for Corneal Ulcers is preclinical, with three drugs in that stage.